Download Documents | |
SDS | USER MANUAL |
CellMosaic® has designed this personalized antibody-oligo conjugation kit to work with any antibody and an amine-modified oligo. The user supplies the amine-modified oligo (preferably a C6 amino modified oligo), which is readily available from many commercial oligo suppliers. Using the kit components, the customer converts the amine-oligo to a maleimide-oligo (Step 1A in Scheme 1). The customer also supplies their own antibody. Using the kit components, the customer converts some of the surface amines of the antibody to free thiol groups (Step 1B in Scheme 1), followed by reaction of the maleimide-modified oligo to generate the conjugates (Step 2 in Scheme 1). If there are any unreacted thiols on the antibody, they are subsequently capped (Step 3 in Scheme 1). The final conjugate is desalted and buffer exchanged with PBS buffer.
This kit provides materials to perform one (CM53405x1) or three (CM53405x3) antibody oligo conjugations. Scale of the reaction: 0.25−1 mg antibody (protein content).
Note to previous users: If you purchased this kit previously, the current one is an upgrade/improved kit with slightly different components from the first-generation kit, including:
Requirement for antibody:
Requirement for amine-oligo (≥5-mer):
Note: You can purchase HPLC purified C6 amino-modified oligo from standard oligo manufacturers up to 90-mer length for this kit preparation. Oligos tested at CellMosaic for this kit were from either Integrated DNA technologies (https://www.idtdna.com/) or TriLink Biotechnologies (https://www.trilinkbiotech.com/). We have not tested oligos made by other oligo manufacturers. It is highly recommended that customers analyze and quantify oligos prior to using them (Disclaimer: CellMosaic has no financial interest in IDT or TriLink).
Key Features of this Antibody-Oligo Conjugation Kit:
Scheme 1: Synthetic route to antibody−oligo conjugate
Typical Kit Performance Data (LC analysis, CellMosaic)
Antibody information: A therapeutic antibody (human IgG1 subtype)
Oligo information: HPLC-purified 18mer oligo with 5’ NH2-C6 modification
Kit lot number: S331.S9.040721
Scale of the reaction: 1 mg of antibody
Specification of the final conjugates:
Calculated average DOL: 1.9 Unreacted antibodies: 9.3%
Unreacted oligo: ~0.5% Conjugate Purity: >90% (85% recovery)
Figure 1: Size-exclusion HPLC analysis of the antibody (Ab, red), oligo (blue), and purified antibody-oligo conjugates (green).